Calamos Advisors’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Calamos Advisors’s Portfolio DIAX Stock Details DIAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,709	Closed	-$392K	–	1221
2025 Q4	$392K	Buy	25,709 +6,255	+32%	+$93K	﹤0.01%	794
2025 Q3	$290K	Buy	19,454 +3,475	+22%	+$50.4K	﹤0.01%	811
2025 Q2	$229K	Sell	15,979 -1,390	-8%	-$19.3K	﹤0.01%	815
2025 Q1	$252K	Sell	17,369 -695	-4%	-$10.5K	﹤0.01%	783
2024 Q4	$272K	Sell	18,064 -1,869	-9%	-$28.3K	﹤0.01%	781
2024 Q3	$296K	Buy	+19,933	New	+$286K	﹤0.01%	760

Other funds holding DIAX

Stolper & Co Tulsa, Oklahoma $387M AUM 25.53% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

PTC

Private Trust Company Cleveland, Ohio $1.25B AUM 29.12% 1-Year Est. Return

Calamos Advisors's DIAX Position: Q1 2026 in Review

Calamos Advisors sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 25,709 shares — an estimated $392K sold.

Calamos Advisors first reported a position in DIAX in Q3 2024 and held it in 6 quarters. The position peaked at $392K in Q4 2025. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.

Calamos Advisors reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
Calamos Advisors sold 25,709 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $392K.
Calamos Advisors first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q3 2024 and held it in 6 quarters.
Calamos Advisors's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $392K in Q4 2025.
3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.

Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.